PMC:7095246 / 14341-15013
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T41","span":{"begin":45,"end":49},"obj":"Body_part"},{"id":"T42","span":{"begin":466,"end":470},"obj":"Body_part"},{"id":"T43","span":{"begin":533,"end":538},"obj":"Body_part"}],"attributes":[{"id":"A41","pred":"fma_id","subj":"T41","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A42","pred":"fma_id","subj":"T42","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A43","pred":"fma_id","subj":"T43","obj":"http://purl.org/sig/ont/fma/fma68877"}],"text":"Table 3 Comparison of the number of affected lung lobes with clinical classification\nNumber of lobes affected Total (78) Light type (24) Common type (46) Severe-critical type (8) Statistic p value*\n0 24 (100%) 24 (100) 0 (0) 0 (0%) – –\n1 8 (10.3%) 0 8 (17.4%) 0 (0%) 0.546 0.460b\n2 6 (7.7%) 0 6 (13.0%) 0 (0%) 0.225 0.635b\n3 5 (6.4%) 0 5 (10.9%) 0 (0%) – 1.000a\n4 10 (12.8%) 0 10 (21.7%) 0 (0%) 0.937 0.333b\n5 25 (32.1%) 0 17 (37.0%) 8 (100%) – 0.001a\nMore than two lung lobes 40 (51.3%) 0 32 (70.0%) 8 (100%) 1.893 0.169b\nBilateral lungs 45 (57.7%) 0 37 (80.4%) 8 (100%) 0.734 0.392b\n*p value: common type vs severe-critical type\naFisher exact test\nbContinuity correction"}
LitCovid-PD-UBERON
{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T49","span":{"begin":45,"end":49},"obj":"Body_part"},{"id":"T50","span":{"begin":466,"end":470},"obj":"Body_part"}],"attributes":[{"id":"A49","pred":"uberon_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A50","pred":"uberon_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"Table 3 Comparison of the number of affected lung lobes with clinical classification\nNumber of lobes affected Total (78) Light type (24) Common type (46) Severe-critical type (8) Statistic p value*\n0 24 (100%) 24 (100) 0 (0) 0 (0%) – –\n1 8 (10.3%) 0 8 (17.4%) 0 (0%) 0.546 0.460b\n2 6 (7.7%) 0 6 (13.0%) 0 (0%) 0.225 0.635b\n3 5 (6.4%) 0 5 (10.9%) 0 (0%) – 1.000a\n4 10 (12.8%) 0 10 (21.7%) 0 (0%) 0.937 0.333b\n5 25 (32.1%) 0 17 (37.0%) 8 (100%) – 0.001a\nMore than two lung lobes 40 (51.3%) 0 32 (70.0%) 8 (100%) 1.893 0.169b\nBilateral lungs 45 (57.7%) 0 37 (80.4%) 8 (100%) 0.734 0.392b\n*p value: common type vs severe-critical type\naFisher exact test\nbContinuity correction"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T106","span":{"begin":45,"end":49},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T107","span":{"begin":45,"end":49},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T108","span":{"begin":236,"end":239},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T109","span":{"begin":323,"end":326},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T110","span":{"begin":466,"end":470},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T111","span":{"begin":466,"end":470},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T112","span":{"begin":533,"end":538},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T113","span":{"begin":539,"end":541},"obj":"http://purl.obolibrary.org/obo/CLO_0053799"},{"id":"T114","span":{"begin":645,"end":649},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Table 3 Comparison of the number of affected lung lobes with clinical classification\nNumber of lobes affected Total (78) Light type (24) Common type (46) Severe-critical type (8) Statistic p value*\n0 24 (100%) 24 (100) 0 (0) 0 (0%) – –\n1 8 (10.3%) 0 8 (17.4%) 0 (0%) 0.546 0.460b\n2 6 (7.7%) 0 6 (13.0%) 0 (0%) 0.225 0.635b\n3 5 (6.4%) 0 5 (10.9%) 0 (0%) – 1.000a\n4 10 (12.8%) 0 10 (21.7%) 0 (0%) 0.937 0.333b\n5 25 (32.1%) 0 17 (37.0%) 8 (100%) – 0.001a\nMore than two lung lobes 40 (51.3%) 0 32 (70.0%) 8 (100%) 1.893 0.169b\nBilateral lungs 45 (57.7%) 0 37 (80.4%) 8 (100%) 0.734 0.392b\n*p value: common type vs severe-critical type\naFisher exact test\nbContinuity correction"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T9","span":{"begin":121,"end":126},"obj":"Chemical"}],"attributes":[{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_30212"}],"text":"Table 3 Comparison of the number of affected lung lobes with clinical classification\nNumber of lobes affected Total (78) Light type (24) Common type (46) Severe-critical type (8) Statistic p value*\n0 24 (100%) 24 (100) 0 (0) 0 (0%) – –\n1 8 (10.3%) 0 8 (17.4%) 0 (0%) 0.546 0.460b\n2 6 (7.7%) 0 6 (13.0%) 0 (0%) 0.225 0.635b\n3 5 (6.4%) 0 5 (10.9%) 0 (0%) – 1.000a\n4 10 (12.8%) 0 10 (21.7%) 0 (0%) 0.937 0.333b\n5 25 (32.1%) 0 17 (37.0%) 8 (100%) – 0.001a\nMore than two lung lobes 40 (51.3%) 0 32 (70.0%) 8 (100%) 1.893 0.169b\nBilateral lungs 45 (57.7%) 0 37 (80.4%) 8 (100%) 0.734 0.392b\n*p value: common type vs severe-critical type\naFisher exact test\nbContinuity correction"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T161","span":{"begin":0,"end":84},"obj":"Sentence"},{"id":"T162","span":{"begin":85,"end":197},"obj":"Sentence"},{"id":"T163","span":{"begin":198,"end":235},"obj":"Sentence"},{"id":"T164","span":{"begin":236,"end":279},"obj":"Sentence"},{"id":"T165","span":{"begin":280,"end":322},"obj":"Sentence"},{"id":"T166","span":{"begin":323,"end":361},"obj":"Sentence"},{"id":"T167","span":{"begin":362,"end":407},"obj":"Sentence"},{"id":"T168","span":{"begin":408,"end":451},"obj":"Sentence"},{"id":"T169","span":{"begin":452,"end":522},"obj":"Sentence"},{"id":"T170","span":{"begin":523,"end":584},"obj":"Sentence"},{"id":"T171","span":{"begin":585,"end":630},"obj":"Sentence"},{"id":"T172","span":{"begin":631,"end":649},"obj":"Sentence"},{"id":"T173","span":{"begin":650,"end":672},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Table 3 Comparison of the number of affected lung lobes with clinical classification\nNumber of lobes affected Total (78) Light type (24) Common type (46) Severe-critical type (8) Statistic p value*\n0 24 (100%) 24 (100) 0 (0) 0 (0%) – –\n1 8 (10.3%) 0 8 (17.4%) 0 (0%) 0.546 0.460b\n2 6 (7.7%) 0 6 (13.0%) 0 (0%) 0.225 0.635b\n3 5 (6.4%) 0 5 (10.9%) 0 (0%) – 1.000a\n4 10 (12.8%) 0 10 (21.7%) 0 (0%) 0.937 0.333b\n5 25 (32.1%) 0 17 (37.0%) 8 (100%) – 0.001a\nMore than two lung lobes 40 (51.3%) 0 32 (70.0%) 8 (100%) 1.893 0.169b\nBilateral lungs 45 (57.7%) 0 37 (80.4%) 8 (100%) 0.734 0.392b\n*p value: common type vs severe-critical type\naFisher exact test\nbContinuity correction"}